Form 4 for CRL Charles River Laboratories
Accepted 2025-05-15 00:00:00 ET · period of report 2025-05-14 · accession 0001127602-25-014486 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-05-15 | 2025-05-14 | CRL | MASSARO GEORGE | Dir | S - Sale | $140.73 | -140 | 5,715 | -2% | -$19.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-14 | S | D | 21 | $140.78 | 5,743 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $140.52 to $141.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024. |
| 2 | Common | Common Stock | 2025-05-14 | S | D | 14 | $141.85 | 5,729 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $141.80 to $141.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024. |
| 3 | Common | Common Stock | 2025-05-14 | S | D | 7 | $143.77 | 5,722 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $143.70 to $143.78. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024. |
| 4 | Common | Common Stock | 2025-05-14 | S | D | 91 | $139.95 | 5,764 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $139.47 to $140.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024. |
| 5 | Common | Common Stock | 2025-05-14 | S | D | 7 | $145.54 | 5,715 | D | — | — | (F5) This sale occurred pursuant to a 10b5-1 trading plan adopted on August 19, 2024. |